Nivolumab Plus Gemcitabine in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma-HN17-11
Clinical trial NCT06440187 · COMPLETED
Trial details
- NCT number
- NCT06440187
- Sponsor
- Seoul National University Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-08
- Primary completion
- 2021-04-30
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.